SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-013639
Filing Date
2018-05-15
Accepted
2018-05-15 16:16:19
Documents
61
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-10q_20180331.htm 10-Q 1143439
2 EX-31.1 vtvt-ex311_9.htm EX-31.1 17628
3 EX-31.2 vtvt-ex312_6.htm EX-31.2 17520
4 EX-32.1 vtvt-ex321_8.htm EX-32.1 7258
5 EX-32.2 vtvt-ex322_7.htm EX-32.2 7213
6 GRAPHIC g201805141437262594275.jpg GRAPHIC 39119
  Complete submission text file 0001564590-18-013639.txt   4950760

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vtvt-20180331.xml EX-101.INS 928452
8 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20180331.xsd EX-101.SCH 51504
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20180331_cal.xml EX-101.CAL 37434
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20180331_def.xml EX-101.DEF 213482
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20180331_lab.xml EX-101.LAB 364169
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20180331_pre.xml EX-101.PRE 287274
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 18836708
SIC: 2834 Pharmaceutical Preparations